Newsbenzinga
Elanco Sees Strong Pet Health Momentum, Bets on Innovative Products
· Published
Article summary
Elanco beat second-quarter estimates, raised 2026 guidance and cited strong Pet Health demand, Zenrelia growth and expanding margins.
An excerpt from the original article.
Comments —
Loading comments…